Lona Gaugler
About Lona Gaugler
Lona Gaugler is the Global Medical Affairs Director for Hematology at Bristol Myers Squibb, based in Boudry, Switzerland, with over a decade of experience in medical affairs and a strong educational background in oncology and molecular medicine.
Company
Lona Gaugler currently works at Bristol Myers Squibb, a prominent global pharmaceutical company. Based in Boudry, Switzerland, Bristol Myers Squibb specializes in pioneering treatments across a range of therapeutic categories, including hematology where Gaugler focuses her expertise.
Title
Lona Gaugler holds the position of Global Medical Affairs, Director in the Hematology division at Bristol Myers Squibb. Her role involves overseeing medical affairs strategies and contributing to the development and dissemination of clinical insights within the hematology field.
Educational Background in Oncology
Lona Gaugler has a robust educational foundation in oncology. She earned a Master of Science (MS) in Advanced Oncology from Universität Ulm between 2011 and 2013. Prior to that, she completed a Master’s degree in Oncology and Molecular Medicine at EPFL (École polytechnique fédérale de Lausanne), where she studied from 2004 to 2008.
Career in Medical Affairs
Lona Gaugler has extensive experience in medical affairs, having worked in this sector for over a decade. She began her career at Celgene, where she served as Associate Director of Medical Affairs in Myeloid Diseases for 12 years, from 2009 to 2021. At Celgene, she developed expertise in myeloid diseases, which she continues to utilize in her current role.
Transition to Bristol Myers Squibb
In 2021, Lona Gaugler transitioned to Bristol Myers Squibb, where she took on the role of Global Medical Affairs, Director in Hematology. This move marked a significant step in her career, enabling her to apply her extensive knowledge and experience in hematologic disorders at a global pharmaceutical giant.
Early Industry Experience
Lona Gaugler gained early industry experience at Venture Valuation AG, where she worked as an intern for 11 months in 2008. This role provided her with foundational insights into the pharmaceutical and biotechnology sectors, setting the stage for her future career in medical affairs and hematology.